You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development and flight test demonstration of an innovative practical Autonomous Formation Flying System (AFFS) for manned rotorcraft.
SBC: Aerotonomy, Incorporated Topic: A05T011Aerotonomy, Incorporated and our Research Institution partner the Georgia Institute of Technology (GIT) will combine an innovative adaptive guidance system, the latest knowledge in autonomous adaptive rotorcraft control, and intuitive pilot interface techniques to arrive at a safe, practical, Autonomous Formation Flying System (AFFS) for manned rotorcraft. This Phase I project will culminate in a ...
STTR Phase I 2005 Department of DefenseArmy -
Transdermal Hydromorphone for Acute and Chronic Pain
SBC: Altea Therapeutics Corporation Topic: N/ADESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This breakthrough technology, currently undergoing Phase 1 clinical trials for basal insulin delivery, revolutionizes the way in which medicine ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Non-Invasive Drug Delivery by Thermal Microporation
SBC: Altea Therapeutics Corporation Topic: N/ADESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) transdermal drug delivery system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This breakthrough technology, currently undergoing Phase 1 clinical trials for transdermal delivery of insulin and ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Diagnostic for Age-Related Macular Degeneration
SBC: APELIOTUS TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): Apeliotus Technologies proposes to develop a commercial diagnostic for the early detection of age-related macular degeneration (ARMD). It relies on a functional test of dark adaptation kinetics (the transition from being light-adapted to being dark-adapted) that has been shown in previous work to detect the onset of ARMD at least four years before it is clinic ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Flavonoid Compounds for the Prevention of Osteoporosis
SBC: Aptotec, Inc. Topic: N/ADESCRIPTION (provided by applicant): Approximately 10 million people in the U.S. are estimated to have osteoporosis, a disease that results in over 1.5 million bone fractures a year. It is now known that the accumulation of fat cells (adipocytes) in bone marrow is a major factor contributing to age-related bone loss. Women with osteoporosis have higher numbers of marrow adipocytes than those wome ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Neural cell based assays derived from human ES cells
SBC: ARUNA BIO, INC. Topic: N/ADESCRIPTION (provided by applicant): Neurons send instructions to other cells in the form of electrical signals that allow movement, sensation, memory, learning and countless other activities that are taken for granted in daily life. Loss of neural cell function results from traumatic injuries such as gunshots wounds or car accidents and from neurodegenerative diseases. The scale of this health p ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Avian transgenesis via site-directed integration
SBC: AviGenics Inc. Topic: N/ADESCRIPTION (provided by applicant): This Phase II SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Chickens are able to produce large amounts of protein in their eggs at relatively low cost. We seek to harness this capability to synthesize pharmaceutical proteins, such as humanized monoclonal antibodies, that are neede ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
ZnO Based Light Emitters for UV/Blue Applications
SBC: CERMET, INC. Topic: A04068The goal of this effort is to grow n and p ZnO thin films by MOCVD on ZnO substrates. The primary objective of this phase I effort will be to grow p-n homojucntion and characterize the LED structure. Bandgap of ZnO will be engineered and heterojunction quantum wells will be grown. The grown device structures will be characterized for structure and quality by X-ray, PL and electron microscopy, The ...
SBIR Phase I 2005 Department of DefenseArmy -
ZnO Based Light Emitters for UV/Blue Applications
SBC: CERMET, INC. Topic: A04068The goal of this program is to develop ZnO based light emitters fabricated on high quality ZnO bulk substrates. The work will focus on enhance doping of the active layers, target alloy concentrations and prototype emitter fabrication.
SBIR Phase II 2005 Department of DefenseArmy -
Development of Alpha-1 Antitrypsin Gene Therapeutic as Treatment for COPD
SBC: Generx+, Inc. Topic: N/ADESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the U.S. and is associated with an imbalance in proteolytic activity in the lungs. Treatment is largely aimed at symptom remediation using bronchodilators and corticosteroids, but these do not treat the underlying disease process. We are developing a gene-based therapy to treat ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health